Christopher Vounasis to Oversee AccuDial Pharmaceutical, Inc.'s Canadian Operations

PALM BEACH GARDENS, FLORIDA--(Marketwire - July 27, 2010) - Christopher Vounasis has been named Director of Canadian Sales & Marketing by AccuDial® Pharmaceutical, Inc. The product line, from the company's over-the-counter (OTC) division, has developed a revolutionary way to better dose children, offering the only rotating labeling system for weight-specific dosing of children's over-the-counter medications.

Vounasis joins AccuDial from PendoPharm, the OTC division of one of the largest Canadian generic pharmaceutical manufacturers, Pharmascience Inc., where he worked for seven years. Starting as a product manager for Private Label, he worked with all Canadian key accounts analyzing and sourcing new product opportunities for the Canadian OTC market, and successfully launching new Private Label mandates. Most recently, he has served as national sales manager for PendoPharm, where he worked with retail outlets nationally and expanded the sales force to achieve impressive growth.

Prior to PendoPharm, Vounasis was international product manager for J. Walter Company Ltd., a surface technologies company. Previous to J. Walter, he held various marketing positions within the high-tech industry.

Vounasis is a member of the Pharmaceutical Marketing Club of Quebec (PMCQ) and has taken courses with the Canadian Professional Sales Association and McGill International Executive Institute. He holds a bachelor of commerce degree in marketing from Concordia University.

In his new position at AccuDial, Vounasis will have direct responsibility for all sales and marketing in Canada. "Chris has an established reputation as a strategist who executes with speed and precision," said Robert Terwilliger, CEO of AccuDial Pharmaceutical, Inc. "We were drawn by his varied experience in unique organizations, and his abilities as a strong communicator and team player. It will be exciting to see his skills at work in this high-performance environment as we continue to aggressively expand our business."

About AccuDial Pharmaceutical:

AccuDial Pharmaceutical's patented, weight-based dosing was designed to effectively administer AccuDial's family of children's pain and fever, allergy, and cough and cold medications. A parent simply rotates the label until their child's weight appears in the viewing window and the correct dose is shown below the weight. A dosing spoon is included in each package so parents can easily measure and administer the medication. Children's AccuDial is the only medication that provides weight-specific dosing using a rotating label. For more information, contact AccuDial Pharmaceutical, Inc. at www.accuratedose.com.

The information contained in this press release includes "forward-looking statements." All statements other than statements of historical facts included in this press release, including the Company's prospects, plans, financial position, and business strategy, may constitute forward-looking statements. These statements are based on the beliefs and assumptions of our management, and on the information currently available to our management at the time of such statements. Forward-looking statements generally can be identified by the words "believes," "expects," "anticipates," "intends," "plans," "estimates," or similar expressions that indicate future events and trends. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, the Company can give no assurance that these expectations will prove to be correct, and the Company's actual results may differ significantly from the results discussed in these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as the result of new information, future events, or otherwise.

Interviews available with Bob Terwilliger, Chairman/CEO, AccuDial Pharmaceutical, and Christopher Vounasis, Canadian Sales & Marketing Director.

To learn more about Children's AccuDial, please visit our website: http://accuratedose.com/?utm_source=camarketwire&utm_medium=pressrelease&utm_campaign=july272010.

For a downloadable photo of Christopher Vounasis, please go to http://flickr.com/gp/venuemarketing/Y3dJB1.